NCT07211048 2026-01-21
Anti CD19 Gene Therapy for B-cell Lymphoma
Anhui Provincial Hospital
Phase NA Recruiting
Clinical Trials
11 trialsNCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT03244176 2024-07-30
AvR-CHOP
Austin Health
Phase EARLY_PHASE1 Active not recruiting
NCT05385263 2022-05-26
Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown
NCT05286164 2022-04-15
Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown
NCT05164770 2021-12-21
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
Shandong Provincial Hospital
Phase 3 Unknown
NCT04152577 2019-11-05
R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL
Shandong Provincial Hospital
Phase 4 Unknown
NCT03569696 2019-04-23
NivoM
Sheba Medical Center
Phase 2 Unknown
NCT03881761 2019-03-21
CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
Henan Cancer Hospital
Phase 1 Unknown
NCT03881774 2019-03-21
Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
Henan Cancer Hospital
Phase 1 Unknown